(Q39659194)
Statements
Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo (English)
Irene Zinonos
Agatha Labrinidis
Michelle Lee
Vasilios Liapis
Shelley Hay
Peter Diamond
David M Findlay
Andreas Evdokiou
1 reference
1 reference
1 reference
1 reference